{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:12:24Z","timestamp":1773850344075,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Doctoral Research Fund of Xi\u2019an Medical College, China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study aimed to investigate the association between serum concentrations of chemokine (C\u2013C Motif) ligand 18 (CCL-18) and interleukin 23 (IL-23) and clinical parameters of chronic obstructive pulmonary disease (COPD). The serum concentrations of CCL-18 and IL-23 were tested by enzyme linked immunosorbent assay (ELISA). The association between their concentrations and clinical parameters of COPD patients were analyzed by linear regression, logistic regression and ROC curve. The results showed that the serum concentrations of CCL-18 and IL-23 in COPD patients were increased compared with healthy people (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and that patients with acute exacerbation of COPD (AECOPD) had higher serum CCL-18 and IL-23 concentrations than stable patients (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Synergistic increase of CCL-18 and IL-23 in COPD patients was positively correlated with COPD patients' higher GOLD grade (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), higher mMRC score (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and longer medical history (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), but negatively correlated with the forced expiratory volume in one second (FEV1)\/forced vital capacity (FVC) (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and FEV1% predicted (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The serum concentrations of CCL-18 and IL-23 were most related to the GOLD grade (OR\u2009=\u20092.764 for CCL-18 and OR\u2009=\u20094.215 for IL-23) and detection of both showed considerable sensitivity (72.57% for CCL-18 and 76.92% for IL-23) and specificity (92.50% for CCL-18 and 77.5% for IL-23) in identifying COPD. Increased serum concentrations of CCL-18 and IL-23 correlated with the disease progression of COPD and they could be used as biomarkers for disease evaluation of COPD.<\/jats:p>","DOI":"10.1038\/s41598-020-73903-6","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T10:03:16Z","timestamp":1603188196000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Association between serum CCL-18 and IL-23 concentrations and disease progression of chronic obstructive pulmonary disease"],"prefix":"10.1038","volume":"10","author":[{"given":"Biaoxue","family":"Rong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congxue","family":"Rong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,20]]},"reference":[{"key":"73903_CR1","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/s0140-6736(17)31222-9","volume":"389","author":"KF Rabe","year":"2017","unstructured":"Rabe, K. F. & Watz, H. Chronic obstructive pulmonary disease. Lancet 389, 1931\u20131940. https:\/\/doi.org\/10.1016\/s0140-6736(17)31222-9 (2017).","journal-title":"Lancet"},{"key":"73903_CR2","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/s0140-6736(19)30427-1","volume":"394","author":"M Zhou","year":"2019","unstructured":"Zhou, M. et al. Mortality, morbidity, and risk factors in China and its provinces, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 394, 1145\u20131158. https:\/\/doi.org\/10.1016\/s0140-6736(19)30427-1 (2019).","journal-title":"Lancet"},{"key":"73903_CR3","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1042\/cs20160487","volume":"131","author":"PJ Barnes","year":"2017","unstructured":"Barnes, P. J. Cellular and molecular mechanisms of asthma and COPD. Clin. Sci. (Lond.) 131, 1541\u20131558. https:\/\/doi.org\/10.1042\/cs20160487 (2017).","journal-title":"Clin. Sci. (Lond.)"},{"key":"73903_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.mcna.2018.12.005","volume":"103","author":"SP Duffy","year":"2019","unstructured":"Duffy, S. P. & Criner, G. J. Chronic obstructive pulmonary disease: Evaluation and management. Med. Clin. N. Am. 103, 453\u2013461. https:\/\/doi.org\/10.1016\/j.mcna.2018.12.005 (2019).","journal-title":"Med. Clin. N. Am."},{"key":"73903_CR5","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.2147\/copd.s177034","volume":"13","author":"R Biaoxue","year":"2018","unstructured":"Biaoxue, R. et al. Correlation of serum levels of HIF-1alpha and IL-19 with the disease progression of COPD: A retrospective study. Int. J. Chron. Obstr. Pulmon. Dis. 13, 3791\u20133803. https:\/\/doi.org\/10.2147\/copd.s177034 (2018).","journal-title":"Int. J. Chron. Obstr. Pulmon. Dis."},{"key":"73903_CR6","doi-asserted-by":"publisher","first-page":"995","DOI":"10.2147\/copd.s82518","volume":"10","author":"E Bagdonas","year":"2015","unstructured":"Bagdonas, E., Raudoniute, J., Bruzauskaite, I. & Aldonyte, R. Novel aspects of pathogenesis and regeneration mechanisms in COPD. Int. J. Chron. Obstr. Pulmon. Dis. 10, 995\u20131013. https:\/\/doi.org\/10.2147\/copd.s82518 (2015).","journal-title":"Int. J. Chron. Obstr. Pulmon. Dis."},{"key":"73903_CR7","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nm.3895","volume":"21","author":"MWL Teng","year":"2015","unstructured":"Teng, M. W. L. et al. IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases. Nat. Med. 21, 719\u2013729. https:\/\/doi.org\/10.1038\/nm.3895 (2015).","journal-title":"Nat. Med."},{"key":"73903_CR8","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nri3707","volume":"14","author":"SL Gaffen","year":"2014","unstructured":"Gaffen, S. L., Jain, R., Garg, A. V. & Cua, D. J. The IL-23-IL-17 immune axis: From mechanisms to therapeutic testing. Nat. Rev. Immunol. 14, 585\u2013600. https:\/\/doi.org\/10.1038\/nri3707 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"73903_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1146\/annurev-med-051914-021944","volume":"67","author":"GE Fragoulis","year":"2016","unstructured":"Fragoulis, G. E., Siebert, S. & McInnes, I. B. Therapeutic targeting of IL-17 and IL-23 cytokines in immune-mediated diseases. Annu. Rev. Med. 67, 337\u2013353. https:\/\/doi.org\/10.1146\/annurev-med-051914-021944 (2016).","journal-title":"Annu. Rev. Med."},{"key":"73903_CR10","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41584-018-0091-8","volume":"14","author":"EM Gravallese","year":"2018","unstructured":"Gravallese, E. M. & Schett, G. Effects of the IL-23-IL-17 pathway on bone in spondyloarthritis. Nat. Rev. Rheumatol. 14, 631\u2013640. https:\/\/doi.org\/10.1038\/s41584-018-0091-8 (2018).","journal-title":"Nat. Rev. Rheumatol."},{"key":"73903_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrrheum.2015.53","volume":"11","author":"E Lubberts","year":"2015","unstructured":"Lubberts, E. The IL-23-IL-17 axis in inflammatory arthritis. Nat. Rev. Rheumatol. 11, 415\u2013429. https:\/\/doi.org\/10.1038\/nrrheum.2015.53 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"73903_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2147\/copd.s42544","volume":"9","author":"G Caramori","year":"2014","unstructured":"Caramori, G., Adcock, I. M., Di Stefano, A. & Chung, K. F. Cytokine inhibition in the treatment of COPD. Int. J. Chron. Obstr. Pulmon. Dis. 9, 397\u2013412. https:\/\/doi.org\/10.2147\/copd.s42544 (2014).","journal-title":"Int. J. Chron. Obstr. Pulmon. Dis."},{"key":"73903_CR13","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00281-016-0561-5","volume":"38","author":"G Caramori","year":"2016","unstructured":"Caramori, G. et al. COPD immunopathology. Semin. Immunopathol. 38, 497\u2013515. https:\/\/doi.org\/10.1007\/s00281-016-0561-5 (2016).","journal-title":"Semin. Immunopathol."},{"key":"73903_CR14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jaip.2015.04.010","volume":"3","author":"CR Bellinger","year":"2015","unstructured":"Bellinger, C. R. & Peters, S. P. Outpatient chronic obstructive pulmonary disease management: Going for the GOLD. J. Allergy Clin. Immunol. Pract. 3, 471\u2013478. https:\/\/doi.org\/10.1016\/j.jaip.2015.04.010 (2015).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"73903_CR15","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.2147\/copd.s139470","volume":"12","author":"DM Halpin","year":"2017","unstructured":"Halpin, D. M., Miravitlles, M., Metzdorf, N. & Celli, B. Impact and prevention of severe exacerbations of COPD: A review of the evidence. Int. J. Chron. Obstr. Pulmon. Dis. 12, 2891\u20132908. https:\/\/doi.org\/10.2147\/copd.s139470 (2017).","journal-title":"Int. J. Chron. Obstr. Pulmon. Dis."},{"key":"73903_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2147\/copd.s118424","volume":"12","author":"AG Dilektasli","year":"2017","unstructured":"Dilektasli, A. G. et al. Serum CCL-18 level is a risk factor for COPD exacerbations requiring hospitalization. Int. J. Chron. Obstr. Pulmon. Dis. 12, 199\u2013208. https:\/\/doi.org\/10.2147\/copd.s118424 (2017).","journal-title":"Int. J. Chron. Obstr. Pulmon. Dis."},{"key":"73903_CR17","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1164\/rccm.201008-1220OC","volume":"183","author":"DD Sin","year":"2011","unstructured":"Sin, D. D. et al. Serum PARC\/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 183, 1187\u20131192. https:\/\/doi.org\/10.1164\/rccm.201008-1220OC (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"73903_CR18","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3899\/jrheum.170518","volume":"45","author":"GA Salazar","year":"2018","unstructured":"Salazar, G. A. et al. KL-6 but not CCL-18 is a predictor of early progression in systemic sclerosis-related interstitial lung disease. J. Rheumatol. 45, 1153\u20131158. https:\/\/doi.org\/10.3899\/jrheum.170518 (2018).","journal-title":"J. Rheumatol."},{"key":"73903_CR19","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1165\/rcmb.2016-0015OC","volume":"55","author":"U Fujii","year":"2016","unstructured":"Fujii, U. et al. IL-23 is essential for the development of elastase-induced pulmonary inflammation and emphysema. Am. J. Respir. Cell Mol. Biol. 55, 697\u2013707. https:\/\/doi.org\/10.1165\/rcmb.2016-0015OC (2016).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"73903_CR20","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1155\/2016\/4173962","volume":"4173962\u20134173962","author":"C Tan","year":"2016","unstructured":"Tan, C. et al. Effects of low-dose and long-term treatment with erythromycin on interleukin-17 and interleukin-23 in peripheral blood and induced sputum in patients with stable chronic obstructive pulmonary disease. Mediators Inflamm. 4173962\u20134173962, 2016. https:\/\/doi.org\/10.1155\/2016\/4173962 (2016).","journal-title":"Mediators Inflamm."},{"key":"73903_CR21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.arbres.2016.08.015","volume":"53","author":"M Montes de Oca","year":"2017","unstructured":"Montes de Oca, M. et al. Classification of patients with chronic obstructive pulmonary disease according to the Latin American Thoracic Association (ALAT) staging systems and the global initiative for chronic obstructive pulmonary disease (GOLD). Arch. Bronconeumol. 53, 98\u2013106. https:\/\/doi.org\/10.1016\/j.arbres.2016.08.015 (2017).","journal-title":"Arch. Bronconeumol."},{"key":"73903_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/resp.13012","volume":"22","author":"CF Vogelmeier","year":"2017","unstructured":"Vogelmeier, C. F. et al. Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Respirology 22, 575\u2013601. https:\/\/doi.org\/10.1111\/resp.13012 (2017).","journal-title":"Respirology"},{"key":"73903_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1471-2466-12-61","volume":"12","author":"C Launois","year":"2012","unstructured":"Launois, C. et al. The modified Medical Research Council scale for the assessment of dyspnea in daily living in obesity: A pilot study. BMC Pulmon. Med. 12, 61. https:\/\/doi.org\/10.1186\/1471-2466-12-61 (2012).","journal-title":"BMC Pulmon. Med."},{"key":"73903_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1465-9921-13-71","volume":"13","author":"V Pinto-Plata","year":"2012","unstructured":"Pinto-Plata, V. et al. Inflammatory and repair serum biomarker pattern: Association to clinical outcomes in COPD. Respir. Res. 13, 71. https:\/\/doi.org\/10.1186\/1465-9921-13-71 (2012).","journal-title":"Respir. Res."},{"key":"73903_CR25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","volume":"187","author":"J Vestbo","year":"2013","unstructured":"Vestbo, J. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 187, 347\u2013365. https:\/\/doi.org\/10.1164\/rccm.201204-0596PP (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"73903_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1136\/bmj.326.7379.41","volume":"326","author":"PM Bossuyt","year":"2003","unstructured":"Bossuyt, P. M. et al. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative. BMJ 326, 41\u201344. https:\/\/doi.org\/10.1136\/bmj.326.7379.41 (2003).","journal-title":"BMJ"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73903-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73903-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73903-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T21:35:13Z","timestamp":1670362513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73903-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,20]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["73903"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-73903-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,20]]},"assertion":[{"value":"6 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17756"}}